CIK 0001062822 · Non-accelerated filer<br>Smaller reporting company
LEXICON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- LXRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 760474169
- Phone
- 2818633000
- Business address
- 2445 TECHNOLOGY FOREST BLVD., SUITE 1100, THE WOODLANDS, TX, 77381
- Former names
- LEXICON PHARMACEUTICALS, INC./DE, LEXICON GENETICS INC/TX
- Open-market buys, last 90 days
- $49,999
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$49,999. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-01 | BARKER SAM L Director | Grant or award · Stock Option (Right to Buy) | +43,478 | 43,478 | ||
| 2026-05-01 | Cheung Ivan Director | Grant or award · Restricted Stock Units | +35,714 | 35,714 | ||
| 2026-05-01 | Cheung Ivan Director | Grant or award · Stock Option (Right to Buy) | +43,478 | 43,478 | ||
| 2026-05-01 | Swain Judith L Director | Grant or award · Restricted Stock Units | +35,714 | 35,714 | ||
| 2026-05-01 | Swain Judith L Director | Grant or award · Stock Option (Right to Buy) | +43,478 | 43,478 | ||
| 2026-05-01 | Sullivan Diane E. Director | Grant or award · Restricted Stock Units | +35,714 | 35,714 | ||
| 2026-05-01 | Sullivan Diane E. Director | Grant or award · Stock Option (Right to Buy) | +43,478 | 43,478 | ||
| 2026-05-01 | DEBBANE RAYMOND Director | Grant or award · Restricted Stock Units | +35,714 | 35,714 | ||
| 2026-05-01 | DEBBANE RAYMOND Director | Grant or award · Stock Option (Right to Buy) | +43,478 | 43,478 | ||
| 2026-04-30 | Artal Participations S.a r.l. Director | Option exercise | +20,421,735 | 175,156,062 | ||
| 2026-04-30 | Artal Participations S.a r.l. Director | Grant or award · Series B Convertible Preferred Stock | +408,434.7 | 408,434.7 | ||
| 2026-04-30 | Artal Participations S.a r.l. Director | Option exercise · Series B Convertible Preferred Stock | −408,434.7 | 0 | ||
| 2026-02-28 | McDermott Wendy SVP, Human Resources | Option exercise | +27,697 | 149,343 | ||
| 2026-02-28 | McDermott Wendy SVP, Human Resources | Option exercise | +52,316 | 201,659 | ||
| 2026-02-28 | McDermott Wendy SVP, Human Resources | Option exercise | +144,393 | 346,052 | ||
| 2026-02-28 | McDermott Wendy SVP, Human Resources | Shares withheld for taxes | −68,107 | $1.47 | $100K | 277,945 |
| 2026-02-28 | McDermott Wendy SVP, Human Resources | Option exercise · Restricted Stock Units | −27,697 | 0 | ||
| 2026-02-28 | McDermott Wendy SVP, Human Resources | Option exercise · Restricted Stock Units | −52,316 | 52,317 | ||
| 2026-02-28 | McDermott Wendy SVP, Human Resources | Option exercise · Restricted Stock Units | −144,393 | 288,787 | ||
| 2026-02-28 | Martens Rachel Yap SVP, Partnerships & Corp Strat | Option exercise | +67,090 | 67,090 |
Page 2 of 15 · 285 trades